Description du projet
Un patch ECG pour accélérer la détection de l’arythmie cardiaque
Les maladies cardiovasculaires seraient responsables de 31 % des décès dans le monde. Les systèmes de holters, qui permettent de surveiller l’électrocardiogramme (ECG), servent généralement pour la détection précoce des maladies et l’intervention médicale, mais ils ne parviennent pas à détecter plus de 80 % des arythmies cardiaques. Grâce au projet HeartService, un patient portera un patch contenant un moniteur ECG qui fournit des données précises et opportunes à un centre de service pour permettre aux cardiologues de poser un diagnostic. Ce patch économique et ces services de données seront introduits en 2019, tandis que la subvention sera utilisée pour déterminer les meilleures stratégies de diffusion du produit dans les pays de l’UE.
Objectif
Cardiovascular disease (CVD) takes the lives of 17.9 million people every year, representing 31% of all global deaths. Early recognition and detection of CVDs is crucial for a patient’s chance of survival. CVD can be discovered by prolonged electrocardiogram (ECG) monitoring. Unfortunately, the chance to detect cardiac arrhythmias with the commonly used Holter systems is less than 20%. In addition, the delay between doctor visit and diagnosis is long (2 weeks), due to waiting lists in hospitals and a lack of Holter devices and resources for analysis. There is a need for cost-effective solutions for ECG monitoring to enable efficient and timely screening of patients with suspected heart problems.
Glanum Medical is a Dutch start-up company developing a small ECG monitor integrated in a patch as a ground-breaking solution that will enable early diagnoses of cardiac patients. This novel ECG patch is accurate, affordable and patient friendly as compared to conventional Holter systems. The company launches a supporting diagnostic service center for centralized diagnosis by cardiologists. Glanum Medical will provide the infrastructure for distribution and collection of the ECG patch data analysis. As such, the company empowers medical doctors to offer fast, cost-effective and high-quality ECG-based diagnosis.
Glanum will introduce its ECG patch and diagnostic services in 2019 at the Dutch market as a showcase of their product. The company has the ambition to rapidly scale-up to the EU market and will use the SME Phase 1 grant to identify the optimal business strategy for exploitation of its product and service in different EU countries. The feasibility study includes analysis of EU healthcare systems, reimbursement strategies, stakeholder needs and market acceptance to facilitate large-scale roll-out from 2021.
Champ scientifique
Programme(s)
Régime de financement
SME-1 - SME instrument phase 1Coordinateur
5652 LD EINDHOVEN
Pays-Bas
L’entreprise s’est définie comme une PME (petite et moyenne entreprise) au moment de la signature de la convention de subvention.